[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351512-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351512-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","changes-in-1-year-relative-survival-of-patients-with-cancer-during-the-covid-19-pandemic-in-denmark-finland-iceland-norway-and-sweden-a-population-based-cohort-study","Changes in 1-year relative survival of patients with cancer during the COVID-19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden - A population-based cohort study","","During the first year of the COVID-19 pandemic, cancer reporting declined across Nordic countries, suggesting delays in diagnosis. This study compares 1-year relative survival and excess mortality for patients diagnosed March–December 2020 against expected outcomes from patients diagnosed 2011–2019. Flexible parametric relative survival models were used, with excess mortality defined as the difference in total mortality between cancer patients and the non-cancer national population.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/changes-in-1-year-relative-survival-of-patients-with-cancer-during-the-covid-19-pandemic-in-denmark-finland-iceland-norway-and-sweden-a-population-based-cohort-study/351512/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/changes-in-1-year-relative-survival-of-patients-with-cancer-during-the-covid-19-pandemic-in-denmark-finland-iceland-norway-and-sweden-a-population-based-cohort-study/351512.png","ImageObject",300,407,{"name":42,"@type":43},"Fahsai","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What time period and cohorts were compared in the study?","Question",{"text":63,"@type":64},"The study compared patients diagnosed with cancer from March–December 2020 in Denmark, Finland, Iceland, Norway, and Sweden against expected outcomes based on patients diagnosed in 2011–2019.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were excess mortality and 1-year relative survival evaluated?",{"text":68,"@type":64},"Excess mortality was defined as the difference in total mortality between patients with cancer and the national population without cancer. One-year relative survival was analyzed using flexible parametric relative survival models.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the study find about survival and mortality during the pandemic?",{"text":72,"@type":64},"One-year relative survival was reduced and excess mortality increased for patients diagnosed during the pandemic period in 2020, with effects most pronounced in older patients and those with more aggressive cancers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351512,1790535936,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","DOI: 10.1002/ijc.70336  \nRES EARCH A RTICLE  \nCa ncer Epidemiology  \nChanges in 1-year relative survival of patients with cancer during the COVID-19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden: A population-based cohort study  \nFernando Gonzalez Yli-Mäyry 1  | Tomas Tanskanen 1 | Karri Seppä 1 |  \nAnna L. V. Johansson 2,3  | Charlotte Wessel Skovlund 4 | Lina Steinrud Mørch 4 | Søren Friis 4 | Simon Mathis Kønig 4 | Tom Børge Johannesen 2 |  \nTor Åge Myklebust 2,5 | Sasha Pejicic 6 | David Pettersson 6 | Eva María Guðmundsdóttir 7 | Sirpa Heinävaara 1,8 | Nea Malila 1 |  \nJoonas Miettinen 1  | Johan Ahlgren 9 | Giske Ursin 2,10,11 | Janne Pitkäniemi 1,8,12 1Finnish Cancer Registry, Cancer Society of Finland, Helsinki, Finland  \n2Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway  \n3Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden 4Danish Cancer Institute, Danish Cancer Society, Copenhagen, Denmark  \n5Department of Research and Innovation, Møre and Romsdal Hospital Trust, Ålesund, Norway 6National Board of Health and Welfare, Stockholm, Sweden  \n7Cancer Registry of Iceland, Icelandic Cancer Society, Reykjavik, Iceland  \n8Department of Public Health, Faculty of Medicine, University of Helsinki, Helsinki, Finland 9Regional Cancer Center Central Sweden, Uppsala, Sweden  \n10Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway  \n11Department of Preventive Medicine, University of Southern California, Los Angeles, California, USA 12Health Sciences Unit, Faculty of Social Sciences, Tampere University, Tampere, Finland  \nCorrespondence  \nFernando Gonzalez Yli-Mäyry, Finnish Cancer Registry, Mäkelänkatu 2, FIN-00500 Helsinki, Finland.  \nEmail: [fernando.gonzalez@cancer.fi](fernando.gonzalez@cancer.fi)  \nFunding information  \nNordic Cancer Union, Grant/Award Number: R276-A15785  \nAbstract  \nDuring the first year of the COVID-19 pandemic, reported cancer cases declined in the Nordic countries, potentially reflecting delays in cancer diagnosis. We compared 1-year relative survival (RS) and excess mortality of patients diagnosed with cancer in the Nordic countries in March–December 2020 with that expected based on patients diagnosed in 2011–2019 . We used flexible parametric RS models, defining excess mortality as the difference in total mortality between patients with cancer and the national population without cancer. We report the ratio between the observed and expected excess mortality (EMR) and the difference in 1-year RS in percentage points  \nAbbreviations: CI, confidence interval; COVID-19, coronavirus disease 2019; EMR, excess mortality ratio; pp, percentage point; RS, relative survival; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2 .  \nFernando Gonzalez Yli-Mäyry and Tomas Tanskanen contributed equally to this study.  \nThis is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.  \n© 2026 The Author(s) . International Journal of Cancer published by John Wiley & Sons Ltd on behalf of UICC.  \n(pp) by country, age, sex, and cancer site. Excess mortality of patients diagnosed during the pandemic was increased in all Nordic countries except Iceland. Swedish men had the highest EMR of 1.12 (95% CI 1.06, 1.17), corresponding to a 1.4 pp reduction in 1-year RS (87 . 1%–85 .8%) . In women, the highest EMR was 1 . 10 (95% CI 1 .03, 1. 18) in Norway, corresponding to a 1-year RS decrease of 1 .2 pp (86 . 6%–85 . 5%) . The largest site-specific decreases in 1-year RS were observed for liver cancer in Finnish and Swedish men, with decreases of 10.2 pp (45.3%–35.1%) and 7.2 pp (55 . 7%–48 . 5%), respectively. We found reduced 1-year RS among Nordic patients diagnosed with cancer during the COVID-19 pandemic in 2020, especially in older patients and those with aggressive cancers. These reductio","cbCaiopi5QLMIaEB","https://ap.wps.com/l/cbCaiopi5QLMIaEB","pdf",866284,11,"English","# Abstract\n## Background and research aim\n## Methods (relative survival and excess mortality)\n## Key findings","[{\"question\":\"What time period and cohorts were compared in the study?\",\"answer\":\"The study compared patients diagnosed with cancer from March–December 2020 in Denmark, Finland, Iceland, Norway, and Sweden against expected outcomes based on patients diagnosed in 2011–2019.\"},{\"question\":\"How were excess mortality and 1-year relative survival evaluated?\",\"answer\":\"Excess mortality was defined as the difference in total mortality between patients with cancer and the national population without cancer. One-year relative survival was analyzed using flexible parametric relative survival models.\"},{\"question\":\"What did the study find about survival and mortality during the pandemic?\",\"answer\":\"One-year relative survival was reduced and excess mortality increased for patients diagnosed during the pandemic period in 2020, with effects most pronounced in older patients and those with more aggressive cancers.\"}]","Changes in 1-year relative survival of patients with cancer during the COVID-19 pandemic in Denmark, Finland, Iceland, Norway, and Sweden - A population-based cohort study | PDF",1790094508,28,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/80fd01d803ed84fef851d13b52dd497b.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2f978f4b4a465c8eb53bcbe7ac55e838.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/579a24f23f7add59ea33827e2a03c68a.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/449491d0f8cd7209f261ee6378ed118c.webp",980,1287]